Search Results - "Houzel, Anne"
-
1
VEB-1 in Achromobacter xylosoxidans from cystic fibrosis patient, France
Published in Emerging infectious diseases (01-11-2006)“…Multidrug-resistant Achromobacter xylosoxidans was recovered from the sputum of a patient with cystic fibrosis. The VEB-1 extended-spectrum β-lactamase was…”
Get full text
Journal Article -
2
Rapid Improvement After Starting Elexacaftor-tezacaftor-ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease
Published in American journal of respiratory and critical care medicine (01-07-2021)“…Elexacaftor-tezacaftor-ivacaftor is a cystic fibrosis transmembrane conductance regulator modulator combination, developed for cystic fibrosis (CF) patients…”
Get full text
Journal Article -
3
Lung sarcoidosis in children: update on disease expression and management
Published in Thorax (01-06-2015)“…Sarcoidosis is a rare lung disease in children. The aim of the present study was to provide update information on disease presentation and progression, patient…”
Get more information
Journal Article -
4
Further description of two individuals with de novo p.(Glu127Lys) missense variant in the ASCL1 gene
Published in Clinical genetics (01-05-2024)“…Achaete-Scute Family basic-helix-loop-helix (bHLH) Transcription Factor 1 (ASCL1) is a proneural transcription factor involved in neuron development in the…”
Get full text
Journal Article -
5
Health‐related quality of life in infants and children with interstitial lung disease
Published in Pediatric pulmonology (01-06-2019)“…Introduction Interstitial lung disease in children (chILD) is a highly heterogeneous group of rare and severe respiratory disorders. The disease by itself, the…”
Get full text
Journal Article -
6
Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis
Published in American journal of respiratory and critical care medicine (15-01-2020)“…Lumacaftor-ivacaftor is a CFTR (cystic fibrosis transmembrane conductance regulator) modulator combination recently approved for patients with cystic fibrosis…”
Get full text
Journal Article -
7
Pancreatic enzyme replacement therapy for young cystic fibrosis patients
Published in Journal of cystic fibrosis (01-01-2009)“…Abstract Maldigestion in cystic fibrosis (CF) affects approximately 90% of patients. As soon as pancreatic insufficiency is identified, enzyme supplementation…”
Get full text
Journal Article -
8
Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis
Published in American journal of respiratory and critical care medicine (15-01-2020)Get full text
Journal Article -
9
Myeloblastin is an Myb target gene: mechanisms of regulation in myeloid leukemia cells growth-arrested by retinoic acid
Published in Blood (15-04-2001)“…A pivotal role has been assigned to Myb in the control of myeloid cell growth. Although Myb is a target of retinoic acid, little is known about the mechanisms…”
Get full text
Journal Article -
10
Proteinase 3 mRNA expression is induced in monocytes but not in neutrophils of patients with cystic fibrosis
Published in FEBS letters (03-09-1999)“…Proteinase 3 (PR3), a serine proteinase which can degrade lung tissue, is present in the cystic fibrosis (CF) sputum. In the present study, PR3 protein and…”
Get full text
Journal Article